A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only
Clinical trial NCT00451178 · COMPLETED
Trial details
- NCT number
- NCT00451178
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2012-02-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.